Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medicare Reimbursement Medical Device

CMS Advisory Panel Provides Some Potential Good News For Glaukos

  • News

Executive Summary

Rate adjustment recommendations to US Medicare could result in less drastic reimbursement cuts for Glaukos than those currently on the table.

You may also be interested in...



JPM 2022: Boston Scientific, Inspire, Nuvasive, Vericel

The annual J.P. Morgan Healthcare Conference includes presentations from major medtech companies describing their experience in 2021 and expectations for 2022 as they continue to cope with the impact of the Omicron surge. Here are some of the highlights from the presentations on the third day of the meeting.

Alcon Sees Big Opportunity In Glaucoma Surgery; Buys Ivantis For $475M

Ivantis markets the Hydrus Microstent for minimally invasive glaucoma surgery, a field Alcon exited three years ago when it pulled its CyPass from the market

Glaukos Takes Another Hit From CMS; Investors Respond Negatively As Stock Falls

The US Medicare agency's new rule for facility fees brings more bad news for Glaukos; Wells Fargo downgrades company’s stock in response.

Table

View full table

Related Content

Medtech Insight

Topics

Related Companies

Tags:
Medicare Reimbursement Medical Device
Latest Headlines

News We’re Watching – US FDA Updates, Digital Therapeutics Legislation, AI Endoscopies, Monkeypox EUA, And New AdvaMed Chair

BSI Notified Body Highlights Crucial Elements Related To EU’s MDR Amending Regulation

Breakthrough Device Coverage Legislation Introduced In House

Cardio Catch-Up: Medtronic, Abbott, Ancora Devices Headline ACC, CRT, THT

See All
UsernamePublicRestriction

Register

MT144393

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By